Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.

Kurokawa C, Iankov ID, Anderson SK, Aderca I, Leontovich AA, Maurer MJ, Oberg AL, Schroeder MA, Giannini C, Greiner SM, Becker MA, Thompson EA, Haluska P, Jentoft ME, Parney IF, Weroha SJ, Jen J, Sarkaria JN, Galanis E.

J Natl Cancer Inst. 2018 Oct 1;110(10):1123-1132. doi: 10.1093/jnci/djy033.

2.

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy.

Iankov ID, Kurokawa CB, D'Assoro AB, Ingle JN, Domingo-Musibay E, Allen C, Crosby CM, Nair AA, Liu MC, Aderca I, Federspiel MJ, Galanis E.

Cancer Gene Ther. 2015 Sep;22(9):438-44. doi: 10.1038/cgt.2015.36. Epub 2015 Aug 14.

3.

Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis.

Shire A, Lomberk G, Lai JP, Zou H, Tsuchiya N, Aderca I, Moser CD, Gulaid KH, Oseini A, Hu C, Warsame O, Jenkins RB, Roberts LR.

Med Epigenet. 2015 Jan-Apr;3(1):1-18.

4.

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.

Galanis E, Atherton PJ, Maurer MJ, Knutson KL, Dowdy SC, Cliby WA, Haluska P Jr, Long HJ, Oberg A, Aderca I, Block MS, Bakkum-Gamez J, Federspiel MJ, Russell SJ, Kalli KR, Keeney G, Peng KW, Hartmann LC.

Cancer Res. 2015 Jan 1;75(1):22-30. doi: 10.1158/0008-5472.CAN-14-2533. Epub 2014 Nov 14.

5.

Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma.

Domingo-Musibay E, Allen C, Kurokawa C, Hardcastle JJ, Aderca I, Msaouel P, Bansal A, Jiang H, DeGrado TR, Galanis E.

Cancer Gene Ther. 2014 Nov;21(11):483-90. doi: 10.1038/cgt.2014.54. Epub 2014 Nov 14.

6.

Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer.

Kisiel JB, Li J, Zou H, Oseini AM, Strauss BB, Gulaid KH, Moser CD, Aderca I, Ahlquist DA, Roberts LR, Shire AM.

J Mol Biomark Diagn. 2013 Aug 3;4(145):1000145.

7.

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells.

Allen C, Opyrchal M, Aderca I, Schroeder MA, Sarkaria JN, Domingo E, Federspiel MJ, Galanis E.

Gene Ther. 2013 Apr;20(4):444-9. doi: 10.1038/gt.2012.62. Epub 2012 Aug 23.

8.

Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).

Opyrchal M, Allen C, Iankov I, Aderca I, Schroeder M, Sarkaria J, Galanis E.

Hum Gene Ther. 2012 Apr;23(4):419-27. doi: 10.1089/hum.2011.158. Epub 2012 Mar 9.

9.

Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.

Oseini AM, Chaiteerakij R, Shire AM, Ghazale A, Kaiya J, Moser CD, Aderca I, Mettler TA, Therneau TM, Zhang L, Takahashi N, Chari ST, Roberts LR.

Hepatology. 2011 Sep 2;54(3):940-8. doi: 10.1002/hep.24487. Epub 2011 Aug 8.

10.

Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors.

Lai JP, Sandhu DS, Yu C, Moser CD, Hu C, Shire AM, Aderca I, Murphy LM, Adjei AA, Sanderson S, Roberts LR.

Liver Int. 2010 Nov;30(10):1522-8. doi: 10.1111/j.1478-3231.2010.02336.x. Epub 2010 Sep 8.

11.

The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation.

Lai JP, Oseini AM, Moser CD, Yu C, Elsawa SF, Hu C, Nakamura I, Han T, Aderca I, Isomoto H, Garrity-Park MM, Shire AM, Li J, Sanderson SO, Adjei AA, Fernandez-Zapico ME, Roberts LR.

Hepatology. 2010 Nov;52(5):1680-9. doi: 10.1002/hep.23848.

12.

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ.

Cancer Res. 2010 Feb 1;70(3):875-82. doi: 10.1158/0008-5472.CAN-09-2762. Epub 2010 Jan 26.

13.

Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.

Msaouel P, Iankov ID, Allen C, Aderca I, Federspiel MJ, Tindall DJ, Morris JC, Koutsilieris M, Russell SJ, Galanis E.

Mol Ther. 2009 Dec;17(12):2041-8. doi: 10.1038/mt.2009.218. Epub 2009 Sep 22.

15.

The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

Aderca I, Moser CD, Veerasamy M, Bani-Hani AH, Bonilla-Guerrero R, Ahmed K, Shire A, Cazanave SC, Montoya DP, Mettler TA, Burgart LJ, Nagorney DM, Thibodeau SN, Cunningham JM, Lai JP, Roberts LR.

J Hepatol. 2008 Sep;49(3):373-83. doi: 10.1016/j.jhep.2008.05.015. Epub 2008 Jun 9.

16.

Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.

Lai JP, Sandhu DS, Yu C, Han T, Moser CD, Jackson KK, Guerrero RB, Aderca I, Isomoto H, Garrity-Park MM, Zou H, Shire AM, Nagorney DM, Sanderson SO, Adjei AA, Lee JS, Thorgeirsson SS, Roberts LR.

Hepatology. 2008 Apr;47(4):1211-22. doi: 10.1002/hep.22202.

17.

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD.

Clin Cancer Res. 2008 Jan 15;14(2):419-27. doi: 10.1158/1078-0432.CCR-07-0523.

18.

The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.

Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):394-402; quiz 267.

19.

SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.

Lai JP, Yu C, Moser CD, Aderca I, Han T, Garvey TD, Murphy LM, Garrity-Park MM, Shridhar V, Adjei AA, Roberts LR.

Gastroenterology. 2006 Jun;130(7):2130-44.

PMID:
16762634
20.

MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.

Baudhuin LM, Roberts LR, Enders FT, Swanson RL, Mettler TA, Aderca I, Stadheim LM, Highsmith WE.

J Cancer Res Clin Oncol. 2006 Mar;132(3):159-62. Epub 2005 Nov 15.

PMID:
16292541
21.

hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.

Lai JP, Chien JR, Moser DR, Staub JK, Aderca I, Montoya DP, Matthews TA, Nagorney DM, Cunningham JM, Smith DI, Greene EL, Shridhar V, Roberts LR.

Gastroenterology. 2004 Jan;126(1):231-48.

PMID:
14699503
22.

Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.

Ferber MJ, Montoya DP, Yu C, Aderca I, McGee A, Thorland EC, Nagorney DM, Gostout BS, Burgart LJ, Boix L, Bruix J, McMahon BJ, Cheung TH, Chung TK, Wong YF, Smith DI, Roberts LR.

Oncogene. 2003 Jun 12;22(24):3813-20.

PMID:
12802289
23.

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.

Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W.

Oncogene. 2002 Jul 18;21(31):4863-71.

24.

Plaque morphology is altered by the label of inorganic components of the cell culture medium.

Botiş S, Cernescu C, Aderca I.

Virologie. 1985 Jan-Mar;36(1):57-8. No abstract available.

PMID:
2988196
25.

[Evaluation of the efficiency of a nutrient medium for in vitro cell cultivation prepared with chemical reagents produced in Romania].

Aderca I, Iftimovici M, Botnariuc I, Popescu M.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1984 Oct-Dec;29(4):341-53. Romanian. No abstract available.

PMID:
6522947
26.

Electron optic aspects of a murine cytomegalovirus strain grown in R1 mouse kidney cell cultures.

Dumitrescu SM, Aderca I, Iftimovici M.

Virologie. 1982 Jul-Sep;33(3):203-10.

PMID:
6293170
27.

Immune precipitation phenomena observed between serum samples from healthy subjects.

Babeş VT, Aderca I.

Virologie. 1981 Jan-Mar;32(1):79-80. No abstract available.

PMID:
6820859
28.

Peculiarities of the virus-host cell relationship in a calf kidney cell line persistently infected with measles virus.

Sorodoc I, Aderca I, Cajal N, Dumitrescu SM, Constantinescu O, Cernescu C.

Acta Virol. 1980 Jun;24(4):253-64.

PMID:
6106376
29.

Nicolae Cajal--60th anniversary.

Aderca I.

Acta Virol. 1979 Nov;23(6):512. No abstract available.

PMID:
44668
30.

Persistent measles virus infection in a calf kidney cell line. Note III. Cellular alterations in the selected chronically infected K-2 cell line.

Sorodoc Y, Aderca I, Cernescu C, Diaconiţá GH, Constantinescu O.

Virologie. 1979 Jul-Sep;30(3):197-205.

PMID:
575453
31.

Stability of antimeasles vaccine under the influence of some physical and chemical factors.

Sorodoc Y, Cernescu C, Aderca I.

Virologie. 1979 Apr-Jun;30(2):135-8.

PMID:
462792
32.

Practical aspects of the storage of herpes simplex virus samples.

Aderca I, Iftimovici M.

Virologie. 1979 Jan-Mar;30(1):5-9. No abstract available.

PMID:
34257
33.

HBsAg detection by micro-ELISA.

Babeş VT, Aderca I.

Virologie. 1978 Apr-Jun;29(2):161. No abstract available.

PMID:
354186
34.

Pitfalls in the sensitivity of HBsAg detection.

Babeş VT, Aderca I.

Virologie. 1978 Apr-Jun;29(2):87-91.

PMID:
97861
35.

Transformation by adenovirus type 12 of rat embryol fibroblasts cultivated in the presence of interferon.

Danielescu G, Anton D, Athanasiu P, Aderca I.

Rev Roum Virol. 1974;11(2):133-40. No abstract available.

PMID:
4366216
36.

The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.

Cepleanu M, Cajal N, Cernescu C, Sorodoc Y, Aderca I, Tigăeru N, Suciu D, Manu S, Ferra A, Biberimoroianu S, Dobrescu A, Lucian M.

Rev Roum Virol. 1973;10(1):8-17. No abstract available.

PMID:
4709858
37.

[Research of Stefan S. Nicolau in the field of general virology].

Aderca I.

Stud Cercet Virusol. 1972;23(3):217-22. Romanian. No abstract available.

PMID:
4566771
38.

Ironic infections with RNA viruses in cell cultures. V. Growth characteristics, viral adsorption and cytogenetic evolution.

Aderca I, Iftimovici M, Nachtigal M.

Rev Roum Inframicrobiol. 1971;8(3):111-21. No abstract available.

PMID:
5152642
39.

[Chronic RNA virus infections in cell cultures. Evolution; mechanism of persistence].

Aderca I.

Stud Cercet Inframicrobiol. 1971;22(4):315-29. Romanian. No abstract available.

PMID:
5127273
40.

Cultivability in vitro of Cercopithecus aethiops renal cells. Attempts at obtaining cell lines.

Aderca I, Iftimovici M.

Rev Roum Inframicrobiol. 1971;8(3):123-8. No abstract available.

PMID:
5005007
41.

[Cultivability in vitro of renal cells of Cercopithecus aethiops. Attempted obtainment of cell lines].

Aderca I, Iftimovici M.

Stud Cercet Inframicrobiol. 1971;22(4):331-7. Romanian. No abstract available.

PMID:
5001764
42.
43.

[Primary cultures of human embryo fibroblasts in virology research of the Institutul de inframicrobiologie].

Aderca I.

Stud Cercet Inframicrobiol. 1967;18(1):3-10. Romanian. No abstract available.

PMID:
6043538
44.

[Properties of R-1CA cell lines obtained from kidney cells of Cercopithecus aethiops cultured in vitro].

Aderca I, Iftimovici M, Ghelerter L, Nachtigal M.

Stud Cercet Inframicrobiol. 1966;17(6):443-9. Romanian. No abstract available.

PMID:
4290767
45.

[Cell cultures in inframicrobiology and microbiology].

Aderca I, Gancevici G.

Microbiol Parazitol Epidemiol (Bucur). 1965 Sep-Dec;10(5):405-10. Romanian. No abstract available.

PMID:
5863226
46.
47.

[ATTEMPTS TO OBTAIN SEVERAL CELLULAR STRAINS IN VITRO. II. STUDY OF STRAIN C-1 EU (HUMAN PLACENTAL CHORION)].

ADERCA I, IFTIMOVICI M, NACHTIGAL M, GHELERTER L.

Stud Cercet Inframicrobiol. 1964;15:529-34. Romanian. No abstract available.

PMID:
14309287
49.

[ATTEMPTS TO OBTAIN CELL LINES IN VITRO. I. STUDY OF LINES P 1 EU (HUMAN EMBRYO LUNG) AND R 1 EU (HUMAN EMBRYO KIDNEY)].

ADERCA I, IFTIMOVICI M, NACHTIGAL M, MIHAIL A.

Stud Cercet Inframicrobiol. 1963;14:761-76. Romanian. No abstract available.

PMID:
14125755
50.

[AN AGAR MEDIUM FOR OBTAINING VIRAL PLAQUES IN PRIMARY CULTURES OF HUMAN EMBRYO CELLS].

ADERCA I, IFTIMOVICI M.

Stud Cercet Inframicrobiol. 1963;14:741-7. Romanian. No abstract available.

PMID:
14125754

Supplemental Content

Loading ...
Support Center